Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACCEPT Trial
NCT05277688Phase 3Recruiting
- Sponsor
- Ruijin Hospital
- Start
- Mar 2022
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 3 trial of Cisplatin micelle injection (HA132) in Cervical Cancer (CC), sponsored by Ruijin Hospital. Started Mar 2022; status: recruiting.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT05277688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05277688.